This review and case report highlights the clinical presentation, diagnosis, and successful anticoagulation management of primary upper extremity deep venous thrombosis associated with hyperhomocysteinemia.
Answers are grounded in this paper and cite their sources.
Anticoagulation may aid symptom relief in hyperhomocysteinemia-associated upper extremity DVT; hypothesis-generating and requires prospective trials before practice change.
Upper extremity deep venous thrombosis (UEDVT) is also known as thrombosis of the axillary-subclavian vein, or Paget-Schroetter syndrome. It has primary and secondary varieties. Once considered rare, over the past decades U.E.D.V.T. has emerged as an increasingly important clinical entity. It makes up approximately 1-4% of all episodes of deep venous thrombosis (DVT) and carries a potential for considerable morbidity. Pulmonary embolism (PE) is present in up to one third of patients.
No takes yet. Share an insight, caveat, or question.
Datey et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: